Julie Steenhuysen
For Julie Steenhuysen's latest contributions to The Japan Times, see below:
H5N1 has been discovered in dairy cows in the U.S. states of Texas, Kansas, New Mexico, Michigan and Idaho.
WORLD / Science & Health
Apr 4, 2024
What to know about bird flu in dairy cows and the risk to humans
Health officials and scientists say the risk to humans remains low, but many questions remain.
Eisai's Alzheimer's drug Leqembi
BUSINESS / Companies
Feb 5, 2024
Eisai sees 'huge' growth potential for Alzheimer's drug in China
The Japanese pharmaceutical firm aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year.
People wait in line to take a COVID-19 oral swab test on a sidewalk in the Harlem neighborhood of New York City on June 20.
WORLD / Science & Health
Aug 25, 2023
Highly mutated COVID variant BA.2.86 found in two more countries
Omicron offshoot BA.2.86 carries more than 35 mutations in key portions of the virus compared with XBB.1.5, the dominant variant through most of 2023.
Japan Times
WORLD / Science & Health
Jul 17, 2023
Alzheimer's diagnosis revamp embraces rating scale similar to cancer
New guidelines would replace terminology such as mild, moderate and severe, instead using a numerical system related to disease progression.
Japan Times
WORLD / Science & Health
Jun 6, 2023
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
Japan Times
WORLD / Science & Health
May 5, 2023
Experimental Alzheimer's drug slowed disease by 35% in trial, Eli Lilly reports
The results provide what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Feb 24, 2023
New bird flu spreading worldwide poses no human pandemic risk, experts say
The changes that have allowed the H5N1 clade virus to infect wild birds so efficiently have made it less likely to infect human cells, according to leading disease experts.
Japan Times
Dec 30, 2022
U.S. considers airline wastewater testing as COVID surges in China
Some experts say such a policy would offer a better solution to tracking the virus and slowing its entry into the U.S. than new travel restrictions.
Japan Times
ASIA PACIFIC / Science & Health
Dec 17, 2022
COVID projections predict over 1 million deaths in China through 2023
As China begins to experience a spike in infections, fears are growing that coronavirus cases could sweep across its 1.4 billion population during the Lunar New Year holiday.
Japan Times
WORLD / Science & Health
Oct 12, 2022
U.S. experts urge anxiety screening for children 8 and older
The recommendation comes at a time of rising rates of diagnosed mental health disorders among American young people.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
WORLD / Science & Health
Sep 9, 2022
Long COVID's link to suicide: Scientists warn of hidden crisis
Long COVID is a complex medical condition that can be hard to diagnose as it has a range of more than 200 symptoms — some of which can resemble other illnesses.
Japan Times
Jul 18, 2022
Years of neglect leaves sexual health clinics ill-prepared for monkeypox
The clinics on the front line of fighting the disease are financially stretched, leaving the U.S. and U.K. ill-equipped to tackle the first major global health test since the pandemic.
Japan Times
WORLD / Science & Health / FOCUS
Mar 25, 2022
Drugmakers and scientists begin the hunt for long COVID treatments
Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.
Japan Times
WORLD / Science & Health
Mar 2, 2022
Nerve damage may explain some cases of long COVID-19, U.S. study shows
The condition arises within three months of a COVID-19 infection and lasts at least two months.
Japan Times
WORLD / Science & Health
Feb 17, 2022
Anthony Fauci says time to start 'inching' back toward normality
Fauci has said U.S. states are facing tough choices in their efforts to balance the need to protect their citizens from infections and growing pandemic fatigue.
Japan Times
WORLD / Science & Health
Jan 11, 2022
U.S. man recovering after 'breakthrough' pig-heart transplant
The surgery is among the first to demonstrate the feasibility of a pig-to-human heart transplant, a field made possible by new gene editing tools.
Japan Times
WORLD / Science & Health / ANALYSIS
Jan 10, 2022
Pandemic fatigue makes the case for boosters a harder sell
Disease experts say that rapidly shifting public health messaging in the face of a quickly mutating virus has bred confusion and mistrust over the benefit of boosters.
Japan Times
Dec 18, 2021
Omicron rewrites the COVID plan for 2022
As the omicron variant gains momentum in Europe and the United States, scientists are rewriting their expectations for the COVID-19 pandemic next year.
Japan Times
Nov 30, 2021
How fast does it spread? Scientists ask whether omicron can outrun delta.
Questions remain over whether the COVID-19 variant will evade vaccine protection and whether it will cause more serious illness.


Historically, kabuki was considered the entertainment of the merchant and peasant classes, a far cry from how it is regarded today.
For Japan's oldest kabuki theater, the show must go on